Table 2.
Index MI Characteristics
| Variable | PCI (n=195) |
MED (n=186) |
|---|---|---|
| Confirmatory evidence of index MI | ||
| Chest pain or equivalent | 189 (96.9) | 185 (99.5) |
| Any positive serum marker | 187 (95.9) | 177 (95.2) |
| ST-T changes, new LBBB | 159 (81.5) | 158 (84.9) |
| ST-elevation or new Q-waves or loss of R-waves | 163 (83.6) | 165 (88.7) |
| High serum marker,* n/N (%) | 101/187 (54.0) | 88/177 (49.7) |
| Therapy during first 24 hours of MI | ||
| Thrombolytic agent only | 46 (23.6) | 39 (21.0) |
| GP IIb/IIIa inhibitor | 7 (3.6) | 10 (5.4) |
| Combination | 4 (2.1) | 1 (0.5) |
| None of the above | 136 (69.7) | 134 (72.0) |
| Unknown | 2 (1.0) | 2 (1.1) |
| Interval from MI to randomization | ||
| ≤7 d | 64 (32.8) | 70 (37.6) |
| 8–14 d | 62 (31.8) | 53 (28.5) |
| 15–28 d | 67 (34.4) | 62 (33.3) |
| ≥29 d | 2 (1.0) | 1 (0.5) |
| Median, d | 10.0 | 10.0 |
LBBB indicates left bundle-branch block; GP, glycoprotein. Values are n (%), unless otherwise indicated.
*
Above-median value of the ratio of the peak serum marker to the upper limit of normal.